Iron Toxicity Logo

For U.S. Healthcare Professionals Only

U.S. Patients

Non-U.S. Residents

Leading experts present clinical data and information about the consequences and management of iron overload in this series of PV Updates.

Addressing the Challenges of Sickle Cell Disease Management

Dr. Paul Swerdlow and Dr. Richard A. Drachtman review the use of transfusion therapy as treatment for sickle cell disease.

View program ›

Paul Swerdlow
Paul Swerdlow, MD
Director of Red Cell Disorders
Barbara Ann Karmanos Cancer Institute
Associate Professor
Wayne State University
Detroit, Michigan
Richard A. Drachtman
Richard A. Drachtman, MD
Interim Chief, Pediatric
Hematology/Oncology Division
The Cancer Institute of New Jersey
Professor of Pediatrics
University of Medicine and Dentistry
of New Jersey
Robert Wood Johnson Medical School
New Brunswick, New Jersey

Print

About Novartis Oncology

Our primary goal is to research and develop new methods to treat cancer better than is possible today.

Learn more

Contact Us | Site Map | About Novartis Oncology

Novartis Oncology Logo

Use of this website is governed by the Terms of Use and Privacy Policy.

Copyright © 2010 Novartis Pharmaceuticals Corporation. All Rights Reserved.